TGFB2 and central nervous system cancer: To investigate the exact relationship between TGF-β2 and LC3B in glioma, we treated the tumor cells with a TGF-β2 dose gradient ranging from 0.1 ng/ml to 10 ng/ml, and after 24 h, Western blotting was used to detect autophagy levels.